Success Stories: In Just 1 Month and 14 Days, a Venezuelan Postdoctoral Fellow in Biotechnologies Gets NIW Approval, Thanks to Premium Processing Upgrade and Our Team

Client’s Testimonial:

“Thank you! It has been great working with you.”

On February 22^nd, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Biotechnologies (Approval Notice).

General Field: Biotechnologies

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: Venezuela

State of Residence at the Time of Filing: Maryland

Approval Notice Date: February 22^nd, 2023

Processing Time: 1 month, 14 days (Premium Processing Requested)

Case Summary:

“[The client’s] work centered on creating a new way to screen for patient receptiveness to immunotherapy is a major achievement. Immunotherapy avoids many of the side effects of chemotherapy, and his work underpins new efforts to identify patients most likely to benefit from immunotherapy in order to reduce the use of chemotherapy. Given his accomplishments, I support [the client’s] continued work in the United States”

This statement was made for a postdoctoral research fellow in biotechnologies by another expert who understood the value of his work for the U.S. This Venezuelan expert wanted to continue testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting and determine molecular mechanisms of various health conditions like inflammatory cardiovascular diseases in order to develop novel treatments. So when he wanted to apply for a National Interest Waiver visa under the EB2 category, he came to NAILG for our assistance.

As is customary, our team worked on his case and used the following information to write an impressive petition for him:

We said that his research advancing his proposed endeavor is of great importance because it directly combats cardiovascular diseases, one of the leading causes of death worldwide.
His proposed endeavor also has broad implications for the United States where heart disease is the leading cause of death for men, women, and most racial and ethnic groups, claiming roughly 700,000 lives every year and costing the U.S. over $300 billion annually.
Due to its clear national importance, his research has in fact been supported with funding from the National Institutes of Health.
Additionally, he has completed at least 2 reviews to date and his research has resulted in 11 peer-reviewed journal articles (5 of them first-authored).
Not only this, but his research has also gone on to influence his peers. That is, his publications have been cited a total of 179 times according to Google Scholar.
To corroborate this information we added 4 letters of support written by other experts in the area.
Finally, we said that he has pursued research directly related to his proposed endeavor of testing new drugs using spectral flow cytometry, extracellular vesicle isolation, and Western blotting for 8 years.

Once the petition was ready, we forwarded it to the USCIS for adjudication. Thanks to the premium processing upgrade and our team’s efforts, the case won approval. We are happy and proud of this achievement and we wish our client the best for the future.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.